Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Drug    save search

Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1
Published: 2023-12-07 (Crawled : 17:00) - biospace.com/
DARE | News | $0.319 -8.15% -8.87% 6.8M twitter stocktwits trandingview |
Health Technology
| | O: -7.52% H: 0.0% C: 0.0%

fda drug bioscience clearance application
Lexaria's Investigational New Drug Application Filing Update
Published: 2023-12-07 (Crawled : 15:30) - biospace.com/
LEXX | News | $1.475 -2.32% -2.37% 42K twitter stocktwits trandingview |
Health Technology
| | O: -8.44% H: 0.0% C: 0.0%

drug update application
Malachite Innovations Retains Investment Banking Firm to Assist in Implementation of Strategic Plan for Cannabinoid Drug Development Business
Published: 2023-12-07 (Crawled : 14:30) - globenewswire.com
MLCT | News | $0.1415 -1.06% 7.2K twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist
VBIO | News | $ 0% twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

drug business
Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1, a Novel Intravaginal Formulation of Tamoxifen for Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy Associated with Menopause
Published: 2023-12-07 (Crawled : 13:00) - globenewswire.com
DARE | News | $0.319 -8.15% -8.87% 6.8M twitter stocktwits trandingview |
Health Technology
| | O: -7.52% H: 0.0% C: 0.0%

fda drug bioscience clearance application
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
Published: 2023-12-07 (Crawled : 06:00) - globenewswire.com
GNFT | News | $3.14 -1.88% -1.91% 48K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

fda rare drug liver review treatment application grants
Scilex Holding Company announces that ZTlido® (lidocaine topical system) will be added as a preferred agent to the Medicaid Preferred Drug List (PDL) in two new states: one Midwestern and one Southern State
Published: 2023-12-06 (Crawled : 14:30) - globenewswire.com
SCLX | $1.08 -5.26% -5.56% 830K twitter stocktwits trandingview |
| | O: 0.0% H: 0.0% C: 0.0%

ztlido drug company state one
Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD
Published: 2023-12-06 (Crawled : 13:00) - globenewswire.com
PHAT | $8.26 -2.48% -2.54% 950K twitter stocktwits trandingview |
Health Technology
| | O: 6.07% H: 0.0% C: 0.0%

voquezna fda drug treatment pharmaceuticals application
Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea
Published: 2023-12-06 (Crawled : 12:30) - globenewswire.com
IXHL | $5.88 -13.15% -15.14% 100K twitter stocktwits trandingview |
Manufacturing
| | O: 24.89% H: 0.0% C: 0.0%

ihl-42 drug candidate update ihl-42x trial
Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE
Published: 2023-12-06 (Crawled : 12:00) - globenewswire.com
OPTN | $1.25 1.63% 1.6% 490K twitter stocktwits trandingview |
Health Services
| | O: -14.89% H: 0.0% C: 0.0%

fda xhance drug review extension application
Neurocrine Biosciences Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia
Published: 2023-12-05 (Crawled : 21:00) - prnewswire.com
NBIX M | $119.97 0.42% 0.42% 880K twitter stocktwits trandingview |
Health Technology
| | O: 3.02% H: 0.0% C: 0.0%

drug food designation therapy
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab)
Published: 2023-12-05 (Crawled : 16:00) - biospace.com/
BMY | News P | $50.16 0.56% 0.0% 14M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

drug opdivo review food application
Leading Pan-European Ferry and Logistics Company, P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff
Published: 2023-12-05 (Crawled : 13:30) - globenewswire.com
INBS | $0.313 -5.15% -5.43% 910K twitter stocktwits trandingview |
Manufacturing
| | O: 10.27% H: 10.92% C: -8.09%

drug solution
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting
Published: 2023-12-05 (Crawled : 12:30) - globenewswire.com
ADPT | $4.67 1.08% 1.07% 970K twitter stocktwits trandingview |
Commercial Services
| | O: 1.07% H: 0.95% C: -6.75%

clonoseq drug biotechnologies cancer blood care meeting
BridgeBio Pharma Announces Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Published: 2023-12-05 (Crawled : 12:30) - bridgebio.com
BBIO | $33.61 3.7% 3.57% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 1.96% H: 0.0% C: 0.0%

pharma drug food treatment application submission
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development
Published: 2023-12-05 (Crawled : 07:00) - prnewswire.com
CLVT | $8.04 1.39% -1.62% 3.6M twitter stocktwits trandingview |
Information
| | O: -1.87% H: 1.27% C: -0.25%

partnership drug life research
Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
Published: 2023-12-04 (Crawled : 23:00) - prnewswire.com
LLY 6 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 0.0% C: 0.0%
VNDA | News | $3.96 -1.98% -2.02% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.13% H: 1.53% C: 0.76%

drug food treatment pharmaceuticals application
Scilex Holding Company announces the addition of ZTlido® (lidocaine topical system) as a preferred agent to the Medicaid Preferred Drug List (PDL) of the State of Tennessee
Published: 2023-12-04 (Crawled : 14:00) - globenewswire.com
SCLX | $1.08 -5.26% -5.56% 830K twitter stocktwits trandingview |
| | O: 10.63% H: 0.0% C: 0.0%

ztlido drug company state
J&J Hires Thousands, Invests Millions in AI-Powered Drug Discovery
Published: 2023-12-04 (Crawled : 13:30) - biospace.com/
JNJ | News | $155.4 -0.78% -0.02% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.98% H: 0.0% C: 0.0%

drug
Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Published: 2023-12-01 (Crawled : 18:00) - globenewswire.com
CMND | $3.735 -7.09% -7.63% 440K twitter stocktwits trandingview |
n/a
| | O: 21.29% H: 0.0% C: 0.0%
SPRC | News | $6.32 -7.87% -8.54% 350K twitter stocktwits trandingview |
Manufacturing
| | O: -0.75% H: 0.0% C: 0.0%

obesity drug pre-clinical positive trial results
Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Published: 2023-12-01 (Crawled : 17:00) - globenewswire.com
CMND | $3.735 -7.09% -7.63% 440K twitter stocktwits trandingview |
n/a
| | O: 21.29% H: 0.0% C: 0.0%

obesity drug pre-clinical positive trial results
Gainers vs Losers
69% 31%

Top 10 Gainers
SLDB | News M | $5.89 72.22% 41.94% 12M twitter stocktwits trandingview |
Health Technology

SVFD | News | $3.09 43.72% 30.42% 64M twitter stocktwits trandingview |

FTEL | $2.04 43.66% 30.39% 110K twitter stocktwits trandingview |

HPCO 4 | $0.4824 41.92% 29.54% 28M twitter stocktwits trandingview |

ALGS | News | $0.6475 -5.06% 26.67% 2.1M twitter stocktwits trandingview |
Health Technology

GTHX | $3.16 30.58% 23.42% 10M twitter stocktwits trandingview |
Health Technology

KEQU | $22.5 27.62% 21.64% 24K twitter stocktwits trandingview |
Producer Manufacturing

GSIT | $3.09 27.16% 21.36% 2.2M twitter stocktwits trandingview |
Electronic Technology

SSKN P | $0.628 25.6% 20.38% 210K twitter stocktwits trandingview |
Health Technology

GLUE | $3.66 22.82% 18.58% 510K twitter stocktwits trandingview |
Professional, Scientific, and T...


Your saved searches
Save your searches and get alerts when important news are released.